Losartan potassium NEW
Price | $33 |
Package | 500mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2024-11-19 |
Product Details
Product Name: Losartan potassium | CAS No.: 124750-99-8 |
Purity: 100% | Supply Ability: 10g |
Release date: 2024/11/19 |
Product Introduction
Bioactivity
Name | Losartan potassium |
Description | Losartan potassium (DuP-753 potassium), an Angiotensin II Receptor Blocker, selectively and competitively inhibits the binding of angiotensin II to the angiotensin I (AT1) receptor. |
Cell Research | An MTT assay is used to measure cell proliferation and viability. For the assay, 5000 cells in 200?μL media per well are seeded in a 96 well plate. After overnight incubation to allow for cell attachment, the medium is removed by suction. MTT at 1?mg/mL concentration in serum-free medium is added and then incubated for 4?h at 37°C. After removal of MTT solution, 100?μL of DMSO is added to dissolve formazan crystals. Absorbance at 570?nm and at 600?nm as a reference is then measured using a microplate reader. The difference in absorbance is thus relative to the extent of cell survival. |
In vitro | Losartan competes with the binding of angiotensin II to AT1 receptors, with an IC50 of 20 nM[1]. At 40 μM, losartan affects ISC and prevents the effect of ANGII on ISC[2]. It significantly reduces Ang II-mediated cell proliferation in endometrial cancer cells, and in combination with anti-miR-155, it exhibits a significantly greater antiproliferative effect compared to each drug alone[3]. |
Storage | store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | H2O : 46.1 mg/mL (100 mM) DMSO : 55 mg/mL (119.3 mM) |
Keywords | Angiotensin Receptor | MK954 | inhibit | Losartan | Losartan potassium | DuP-753 | DuP753 | MK-954 | Inhibitor |
Inhibitors Related | Tranilast | Enalapril Maleate | Azilsartan Methyl Ester | Sacubitril/Valsartan | Azilsartan | Irbesartan | Losartan | Ramipril | Captopril | Valsartan Methyl Ester |
Related Compound Libraries | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Drug Repurposing Compound Library | Angiogenesis related Compound Library | Inhibitor Library | Endocrinology-Hormone Compound Library | FDA-Approved Drug Library | Orally Active Compound Library | Bioactive Compounds Library Max | Anti-Hypertension Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$33.00/500mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2024-11-19 | |
$0.00/1KG |
VIP4Y
|
Sinoway Industrial co., ltd.
|
2024-06-27 | |
$0.00/1kg |
VIP1Y
|
Shaanxi TNJONE Pharmaceutical Co., Ltd
|
2024-05-08 | |
$50.00/1kg |
Anhui Ruihan Technology Co., Ltd
|
2023-09-08 | ||
$30.00/1kg |
Henan Bao Enluo International TradeCo.,LTD
|
2023-07-03 | ||
$94.00/10kg |
VIP3Y
|
Hebei Dangtong Import and export Co LTD
|
2023-03-02 | |
$200.00/1kg |
Hebei Mingeng Biotechnology Co., Ltd
|
2022-11-28 | ||
$0.00/25KG |
VIP5Y
|
Hebei Mojin Biotechnology Co., Ltd
|
2022-07-18 | |
$100.00/1kg |
Hebei Linwo New Material Technology Co., LTD
|
2022-07-05 | ||
$10.00/1kg |
Jiangsu Bangdeya New Material Technology Co.,Ltd
|
2022-04-25 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hills
INQUIRY